Drug Name: Ngenla
Indications: To treat growth failure due to inadequate secretion of endogenous growth hormone.
Active Ingredient: Somatrogon-ghla
Company: Pfizer Inc, OPKO Health Inc
Approval Date: 6/27/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761184Orig1s000Corrected_lbl.pdf